EBiSC

EBiSC

Details

DC Role: 
Project Partner
Duration: 
1 Jan 2014 - 31 Dec 2017
Client: 
Innovative Medicines Initiative, European Commission (IMI)

ABOUT THIS PROJECT

The goal of European Bank for induced Stem Cells (EBiSC) coordinated by Pfizer Ltd. and managed by Roslin Cells Sciences Ltd. is to establish the supply chain for research-grade human induced pluripotent stem cells (iPSC) with a non-for-profit Biobank in its core.

The Biobank will provide the distribution of disease-relevant quality-controlled iPSC lines, data and services to any qualified user.

Our responsibility is to develop the EBiSC information management system (IMS) and support the business requirement of EBiSC users.

Latest Tweets

Douglas Connect (3 days ago)
RT @DanyX23: Finally got around to watching the recording of my first conference talk about @elmlang. I think it works quite well to introd…
Douglas Connect (3 days ago)
Our Senior Software Developer, Daniel Bachler, at GOTO 2017 https://t.co/wZ5rYYnju2
Douglas Connect (6 days ago)
RT @eNanoMapper: survey results and outlook paper by an US-EU collaboration about the future of data integration for nanosafety, including…
Douglas Connect (1 week ago)
RT @eNanoMapper: new paper: "toxFlow: a Web-Based Application for Read-Across Toxicity Prediction using Omics and Physicochemical Data" htt…
Douglas Connect (2 weeks ago)
Last chance to apply for 2018 OpenTox internships (deadline Jan 15th) The goal of OpenTox is to develop an interope… https://t.co/IcIoRWQohc

Get in touch

  • Address: Douglas Connect GmbH
    Technology Park Basel
    Hochbergerstrasse 60C
    CH-4057 Basel / Basel-Stadt
    Switzerland
  • Phone: +41 61 851 0170
  • Email: info@douglasconnect.com